Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 



Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 16, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html


Challenges and Opportunities for Understanding and Treating Small Cell Lung Cancer

The NCI is seeking broad input from the scientific community to identify areas of need and opportunity for small cell lung cancer (SCLC).

Application Deadline: November 18, 2018



Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine

The purpose of this FOA is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials.

Application Deadline: November 19, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-841.html 


Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research

Through this I-Corps™ at NIH program FOA, NIH and CDC provide administrative supplement awards to currently-funded SBIR and STTR Phase I grantees.

Application Deadline: November 19, 2018



Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

The purpose of this FOA is to promote the discovery of strong candidate biomarkers and endpoints  for pain that can be used to facilitate the development of non-opioid  pain therapeutics from discovery through Phase II clinical trials. 

Application Deadline: November 27, 2018


Analytical and/or Clinical Validation of a Candidate Biomarker for Pain

The overarching purpose of FOA is to promote the validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-opioid pain therapeutics from discovery through Phase II clinical trials.

Application Deadline: November 27, 2018



Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21/R01)

This R21 NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of pain target discovery and validation projects

Application Deadline: November 27, 2018



Breast Cancer Alliance Education and Outreach Grant

This grant supports programs directly related to outreach and case managerial breast cancer services, including education, counseling, biopsies and mammograms for the underserved.

Application Deadline: November 30, 2018



NIH Clinical and Translational Science Award (CTSA) Program SPIRiT Call for Proposals

SPIRiT, the Sharing Partnership for Innovative Research in Translation, is pleased to announce a new funding program that supports pilot research projects representing collaborations between investigators from at least two of the SPIRiT sites.

Application Deadline: November 30, 2018



Marsha Rivkin Center for Ovarian Cancer Research 

Every year, the Rivkin Center funds promising research in ovarian cancer, selecting researchers and studies through a highly competitive process.

• Pilot Study Program: To support investigator-initiated projects in all areas of ovarian cancer research. Application Deadline: December 3, 2018
• Scientific Scholar Awards: To assist promising laboratory and clinical scientists, who have novel ideas and fresh approaches to scientific challenges, in pursuing a career as an independent investigator in ovarian cancer research. Application Deadline: December 3, 2018



Damon Runyon Physician-Scientist Training Award

This Award is designed to encourage and recruit outstanding U.S. Specialty Board eligible physicians to pursue cancer research careers.

Application Deadline: December 3, 2018



Emerging Global Leader Award

This FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development.

Application Deadline: December 4, 2018


Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium

This FOA, issued by the NCI, is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research.

Application Deadline: December 7, 2018


Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network

The purpose of this administrative supplement is to support a strengthening of community outreach capacity by working through the National Outreach Network (NON).

Application Deadline: December 15, 2018



Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program

Through this FOA, the NCI intends to: support seven region-based “hubs” or networks to facilitate underrepresented investigator/trainee recruitment and career/professional development; provide enhanced capacity in the area of cancer health disparities research; and promote CHD research-related infrastructure development and evaluation.

Application Deadline: December 17, 2018



Pediatric Immunotherapy Discovery and Development Network (PI-DDN) (U54 and U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to establish centers of collaborating investigators with the goal of identifying and  advancing research opportunities for translating immunotherapy concepts  for children and adolescents with cancer toward clinical applications.

Application Deadline: December 17, 2018


Alex's Lemonade Stand Foundation Grants

The innovative grant program funds crucial research that can make a real and important difference for children with cancer.

• Epidemiology Grant: To support the research of investigators who have a specific focus on the epidemiology of childhood cancer, early detection of childhood cancer, or the prevention of childhood cancer. Application Deadline: December 17, 2018 Earliest 
• Young Investigator Grant: To fill the need for startup funds for less experienced researchers to pursue promising research ideas, as well as encourage and cultivate the best and brightest researchers of the future and lead to long-term research projects. Application Deadline: December 17, 2018

https://www.alexslemonade.org/researchers-reviewers/applicants


Elsa U. Pardee Foundation Research Grants

These grants fund research directed toward identifying new treatments or cures for cancer and are designed to allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.

Application Deadline: December 31, 2018



Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42) (R43/R44)

The goal of this FOA is to solicit applications from small business concerns (SBCs) to initiate early research ultimately leading to the commercialization of understudied proteins identified in the "Illuminating the Druggable Genome" project.

Application Deadline: January 5, 2019



NCCN Taiho Trifluridine/Tipiracil Research Grant

NCCN is pleased to announce that it is collaborating with Taiho Oncology, Inc. to offer a new opportunity for the design and performance of clinical and correlative studies of trifluridine/tipiracil, in the treatment of gastrointestinal (GI) malignancies and other solid tumors.

Application Deadline: January 7, 2019



Mark Foundation for Cancer Research ASPIRE Award

ASPIRE Awards are designed to enable innovative approaches to solving high-impact problems in cancer research that tend to fall outside the scope of other funding opportunities.

Application Deadline: January 7, 2019



Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) 

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to increase case ascertainment and appropriate follow-up care, optimizing the  delivery of evidence-based healthcare for individuals at high risk of  cancer due to an inherited genetic susceptibility. 

Application Deadline: January 9, 2019 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-017.html 

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)

This FOA is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging tools for planning and validating radiation therapy treatment strategies in clinical trials.

Application Deadline: January 9, 2019


Communication and Decision Making for Individuals with Inherited Cancer Syndromes

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer.

Application Deadline: January 9, 2018


Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)

This FOA is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging tools for planning and validating radiation therapy treatment strategies in clinical trials.

Application Deadline: January 9, 2019


NCI Research Specialist Award (R50)

This award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.

Application Deadline: January 11, 2019

https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/r50


NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

This FOA invites grant applications for the Research  Specialist Award (R50) in any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019



NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

Through this FOA, the NCI invites grant applications for the Research Specialist Award (R50) in  any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019



Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this specific FOA is to expand Cancer Immunoprevention Research Projects as components of IOTN, which also includes Cancer Immunotherapy Research Projects.

Application Deadline: February 8, 2019


Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to expand organ site-specific Cancer Immunotherapy Research Projects as components of IOTN.

Application Deadline: February 8, 2019


Accelerating Colorectal Cancer Screening and follow-up through Implementation Science

The purpose of this FOA is to promote research in colorectal cancer screening, follow-up, and referral-to-care in regions of the United States where screening rates are below national standards.

Application Deadline: February 11, 2019


Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA intends to create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. 

Application Deadline: February 11, 2019 


Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to develop Immuno-engineering to Improve Immunotherapy (i3) Centers, as new components of the Immuno-Oncology Translation Network (IOTN).

Application Deadline: February 11, 2019


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research

This FOA encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Application Deadline: February 11, 2019



The NCI Predoctoral to Postdoctoral Fellow Transition Award

The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Application Deadline: February 22, 2019


Yale Scholars in Implementation Science (YSIS) Career Development Program

The YSIS Career Development Program is an NIH-funded K12 program within the Yale Center for Implementation Science at the Yale School of Medicine. Funded by the NIH’s National Heart, Lung, and Blood Institute, it is designed to train junior faculty and postdoctoral fellows late-stage dissemination and implementation science.

Application Deadline: March 1, 2019



Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing research for commercial development of novel cancer-relevant technologies.

Application Deadline: April 5, 2019

View the SBIR grant application>>


Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries, and low-resource settings in the US.

Application Deadline: April 5, 2019

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants.  


NCCN Foundation 2019 Young Investigator Award (YIA) Request for Proposals 

Through the YIA Program, the NCCN Foundation invites proposals from early career investigators with innovative ideas and an interest in improving the quality, effectiveness, and efficiency of care provided to cancer patients. Yale will nominate one candidate to apply for the award.

Internal Application Deadline: November 25, 2018



YCC 2018 Class of ’61 Cancer Research Award

This annual Award recognizes significant accomplishment in cancer research at Yale University by a young member of the faculty, coupled with the expectation for future outstanding contributions to our understanding of the causes of cancer and to the development of novel cancer treatments.

Nomination Deadline: November 30, 2018



Applications for the Yale Cancer Center K12 Calabresi Immuno-Oncology Training Program (IOTP) Scholar Awards

We are pleased to solicit applications for the Yale Cancer Center (YCC) K12 Calabresi Immuno-Oncology Training Program (IOTP) Scholar Award for junior faculty to enhance research skills beyond the training provided during graduate and postgraduate training. Successful applicants are required to demonstrate a strong commitment to a career in cancer immunology.  The two-year IOTP curriculum includes didactic and practical training in basic, translational and clinical aspects of cancer immunology research. The program also includes a required research component (either clinical or bench research, or a combination thereof). Applicants will be funded for up to 75% effort and can receive up to $27,800 per year for research expenses. Applicants are required to identify a mentor and a provide a research and mentorship proposal. For additional information and questions, please contact Meina Wang, PhD (meina.wang@yale.edu) or Harriet Kluger, MD (harriet.kluger@yale.edu).
 
Application Deadline: December 1, 2018 at 5:00 PM EST



Lion Heart Fund for Cancer Research 2019

The Lion Hearts are committed to finding a cure for cancer, and breast cancer in particular. Yale investigators are encouraged to submit proposals of innovative, high-potential projects requiring pilot funding.

Application Deadline: December 4, 2018



The NCI Predoctoral to Postdoctoral Fellow Transition Award

The purpose of this Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Internal Deadline: December 13, 2018


Luminary Award of Excellence

The YNHH Smilow Luminary Award of Excellence will serve to recognize, and ceremoniously acknowledge, those individuals and/or teams who consistently exceed performance expectations and deliver high quality cancer care for our patients, families and the health system through community service, optimization/ innovative solutions, patient experience, leadership and research initiatives. Nominations should be submitted directly to Luminary@ynhh.org